HIGH-AFFINITY BINDING-SITES FOR ACTIVATED PROTEIN-C AND PROTEIN-C ON CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS - INDEPENDENT OF PROTEIN-S AND DISTINCT FROM KNOWN LIGANDS
N. Bangalore et al., HIGH-AFFINITY BINDING-SITES FOR ACTIVATED PROTEIN-C AND PROTEIN-C ON CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS - INDEPENDENT OF PROTEIN-S AND DISTINCT FROM KNOWN LIGANDS, Thrombosis and haemostasis, 72(3), 1994, pp. 465-474
Activated protein C (APC) is an antithrombotic serine proteinase havin
g anticoagulant, profibrinolytic and anti-inflammatory activities. Des
pite its potential clinical utility, relatively little is known about
its clearance mechanisms. In the present study we have characterized t
he interaction of APC and its active site blocked forms with human umb
ilical vein endothelial eels (HUVEC). ht 4 degrees C I-125-APC bound t
o HUVEC in a specific, time dependent, saturable and reversible manner
. Scatchard analysis of the binding, isotherm demonstrated a K-d value
of 6.8 nM and total number of binding sites per cell of 359,000. Simi
lar binding isotherms were obtained using radioiabeled protein C (PC)
zymogen as well as D-phe-pro-arg-chloromethylketone (PPACK) inhibited
APC indicating that a functional active site was not required. Competi
tion studies showed that the binding of APC, PPACK-APC and PC were mut
ually exclusive suggesting that they bound to the same site(s). Proteo
lytic removal of the N-terminal gamma-carboxyglutamic acid (gla) domai
n of PC abolished its ability to compete indicating that the gla-domai
n was essential for cell binding. Surprisingly, APC binding to these c
ells appeared to be independent of protein S, a cofactor of APC genera
lly thought to be required for its high affinity binding to cell surfa
ces. The identity of the cell binding site(s), for the most part, appe
ared to be distinct from other known APC ligands which are associated
with cell membranes or extracellular matrix including phospholipid, th
rombomodulin, factor V, plasminogen activator inhibitor type 1 (PAI-1)
and heparin. Pretreatment of HUVEC with antifactor VIII antibody caus
ed partial inhibition of I-125-APC binding indicating that factor VIII
or a homolog accounted for similar to 30% of APC binding. Studies of
the properties of surface bound I-125-APC or I-125-PC and their fate a
t 4 degrees C compared to 37 degrees C were consistent with associatio
n of similar to 25% of the initially bound radioligand with an endocyt
ic receptor. However, most of the radioligand appeared not to be bound
to an endocytic receptor and dissociated rapidly at 37 degrees C in a
n intact and functional state. These data indicate the presence of spe
cific, high affinity binding sites for APC and PC on the surface of HU
VEC. While a minor proportion of binding sites may be involved in endo
cytosis, the identity and function of the major proportion is presentl
y unknown. It is speculated that this putative receptor may be a furth
er mechanisms of localizing the PC antithrombotic system to the vascul
ar endothelium.